Implementation of Electronic Chemotherapy Ordering: An Opportunity to Improve Evidence-Based Oncology Care
by Robert S. Miller, MD. Dr. Kerin Adelson discusses the implementation of Epic’s Beacon chemotherapy ordering platform at the Tisch Cancer Institute of Mt. Sinai, New York, and introduces a new quality metric called the rate of evidence-based adherence (REBA), used to measure clinic and provider performance and increase evidence-based practice.
